Ultragenyx Pharmaceutical Inc. (RARE)

NMS – Real Time Price. Currency in USD

26.86

-0.10 (-0.37%)

Market open: Aug 12, 2026, 3:47 PM EDT

26.90

-0.06 (-0.22%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

673M

560M

434M

363M

Cost of goods sold

-136M

-107M

-67M

-43M

Gross Profit

537M

453M

367M

320M

Operating expenses (excl. COGS)

-1.07B

-989M

-936M

-969M

Operating Income

-535M

-536M

-569M

-649M

Non-operating income, total

-36M

-32M

-39M

-53M

Pretax income

-571M

-568M

-608M

-702M

Equity in earnings

Taxes

-4M

-2M

-6M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-575M

-569M

-607M

-707M

Discontinued operations

Net income

-575M

-569M

-607M

-707M

Dilution adjustment

Preferred dividends

Ultragenyx Pharmaceutical Inc. (RARE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ultragenyx Pharmaceutical Inc. (RARE)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Ultragenyx Pharmaceutical Inc. (RARE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ultragenyx Pharmaceutical Inc. (RARE)

Income Statement (Annual)

Income Statement (Annual)